Effect of Nintedanib on Exercise Capacity in Patients with Idiopathic Pulmonary Fibrosis (IPF): Results from a Phase IIIb Trial

被引：0
|
作者：
Lancaster, L. H. [1 ]
Conoscenti, C. S. [2 ]
Ilowite, J. [3 ]
Trampisch, M. [4 ]
Mogulkoc, N. [5 ]
Homik, L. [6 ]
Kaye, M. [7 ]
机构：
[1] Vanderbilt Univ, Med Ctr, Nashville, TN USA
[2] Boehringer Ingelheim Pharmaceut Inc, 90 E Ridge POB 368, Ridgefield, CT 06877 USA
[3] NYU Winthrop, Div Pulm & Crit Care, Mineola, NY USA
[4] Boehringer Ingelheim Pharma GmbH & Co KG, Ingelheim, Germany
[5] Ege Univ, Sch Med, Izmir, Turkey
[6] Winnipeg Clin, Winnipeg, MB, Canada
[7] Minnesota Lung Ctr Ltd, Minneapolis, MN USA
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2018年 / 197卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A4266
引用
收藏
页数：2
相关论文
共 50 条
  • [41] The effect of pirfenidone on impaired lung function in patients with idiopathic pulmonary fibrosis (IPF) from Czech IPF registry
    Zurkova, Monika
    Kolek, Vitezslav
    Lostakova, Vladimira
    Kriegova, Eva
    Sterclova, Martina
    Bartos, Vladimir
    Doubkova, Martina
    Binkova, Ilona
    Svoboda, Michal
    Strenkova, Jana
    Plackova, Martina
    Lacina, Ladislav
    Rihak, Vladimir
    Petrik, Frantisek
    Lisa, Pavlina
    Bittenglova, Radka
    Tyl, Richard
    Ondrejka, Gustav
    Suldova, Hana
    Lnenicka, Jaroslav
    Psikalova, Jana
    Snizek, Tomas
    Homolka, Jiri
    Kralova, Renata
    Kervitzer, Jan
    Vasakova, Martina
    EUROPEAN RESPIRATORY JOURNAL, 2016, 48
  • [42] Bexotegrast in Patients with Idiopathic Pulmonary Fibrosis The INTEGRIS-IPF Clinical Trial
    Lancaster, Lisa
    Cottin, Vincent
    Ramaswamy, Murali
    Wuyts, Wim A.
    Jenkins, R. Gisli
    Scholand, Mary Beth
    Kreuter, Michael
    Valenzuela, Claudia
    Ryerson, Christopher J.
    Goldin, Jonathan
    Kim, Grace Hyun J.
    Jurek, Marzena
    Decaris, Martin
    Clark, Annie
    Turner, Scott
    Barnes, Chris N.
    Achneck, Hardean E.
    Cosgrove, Gregory P.
    Lefebvre, Eric A.
    Flaherty, Kevin R.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 210 (04) : 424 - 434
  • [43] Variation in Treatment Efficacy of Nintedanib for Idiopathic Pulmonary Fibrosis (IPF) Over 2 Years
    Arai, N.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
  • [44] INHALED INTERFERON AND DIFFUSION CAPACITY IN IDIOPATHIC PULMONARY FIBROSIS (IPF)
    Skaria, S. D.
    Yang, Jie
    Condos, Rany
    Smaldone, G. C.
    SARCOIDOSIS VASCULITIS AND DIFFUSE LUNG DISEASES, 2015, 32 (01) : 37 - 42
  • [45] Predicted Versus Observed Mortality in Clinical Trials of Nintedanib in Idiopathic Pulmonary Fibrosis (IPF)
    Ryerson, C. J.
    Wijsenbeek, M.
    Bonella, F.
    Spagnolo, P.
    Stansen, W.
    Stowasser, S.
    Richeldi, L.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [46] Effect of Pulmonary Rehabilitation Program on Exercise Tolerance and Functional Capacity in Patients with Idiopathic Pulmonary Fibrosis
    Vainshelboim, Baruch
    Oliveira, Jose
    Yohoshua, Liora
    Wais, Israela
    Kramer, Mordechai R.
    MEDICINE AND SCIENCE IN SPORTS AND EXERCISE, 2013, 45 (05): : 543 - 543
  • [47] Idiopathic pulmonary fibrosis (IPF): observations from a Phase 2 trial of GLPG1205 (PINTA)
    Strambu, Irina Ruxandra
    Fagard, Liesbeth
    Ford, Paul
    Van der Aa, Tom
    De Haas-Amatsaleh, Angela
    Santermans, Eva
    Seemayer, Christian
    EUROPEAN RESPIRATORY JOURNAL, 2020, 56
  • [48] Nintedanib plus Sildenafil in Patients with Idiopathic Pulmonary Fibrosis
    Kolb, Martin
    Raghu, Ganesh
    Wells, Athol U.
    Behr, Juergen
    Richeldi, Luca
    Schinzel, Birgit
    Quaresma, Manuel
    Stowasser, Susanne
    Martinez, Fernando J.
    NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (18): : 1722 - 1731
  • [49] Nintedanib Treatment for Elderly Patients with Idiopathic Pulmonary Fibrosis
    Ochi, Y.
    Kato, M.
    Sasaki, S.
    Nakamura, T.
    Yamada, T.
    Ihara, H.
    Takahashi, F.
    Takahashi, K.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
  • [50] The efficacy of a walk-bike on quality of life and exercise capacity in patients with idiopathic pulmonary fibrosis (IPF). A pilot study
    Stessel, Maarten
    Wapenaar, Monique
    Huremovic, Jasmina
    Bendstrup, Elisabeth
    Molina, Maria
    Wijsenbeek, Marlies
    EUROPEAN RESPIRATORY JOURNAL, 2015, 46
12345